Wird geladen...
Overview of Lung Cancer Immunotherapy
Anti–PD-(L)1 therapy represents a turning point in lung cancer immunotherapy, moving from previously ineffective enhancer strategies to immune checkpoints as standard first- and second-line therapies. This unprecedented success highlights the importance of mechanisms to escape immune attack, such PD...
Gespeichert in:
| Veröffentlicht in: | Cancer J |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8175029/ https://ncbi.nlm.nih.gov/pubmed/33298718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000488 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|